BANGKOK, Nov 20 (Bernama): Thailand’s Chulalongkorn University is expected to start the production of its mRNA Covid-19 vaccine, ChulaCov19, in the first quarter of next year.
Head of the Covid-19 vaccine development project Dr Kiat Ruxrungtham said ChulaCov19 will enter its third phase of human trials, with jabs scheduled to be administered in the first quarter of 2022 as well.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
